biotech
Bayer-Schering Pharmaceuticals: A $20B Merger?
Filed in archive Corporate and Industrial News by ruth on April 13, 2006
Bayer-Schering Pharmaceuticals: A $20B Merger?
Yes, that's right. If Schering accepts the bid, two of Germany's biggest pharmaceutical companies would merge and operate under one name. Bayer AG offered $20.01 billion, equivalent to $104.28 per share, making the other contender, Merck KGaA, abandon the takeover bidding. The impacts of this potential merger?
The planned merger of Schering AG and the Bayer pharmaceuticals division will create a new heavyweight of international standing in pharmaceutical specialty products.

It is also expected to result in the loss of some 6,000 jobs from the combined work force of about 60,000.

The combined company is to be named Bayer-Schering Pharmaceuticals and have its headquarters in Berlin.




Permalink: Bayer-Schering Pharmaceuticals: A $20B Merger?
Tags: merger  pharmaceutical  biotech  pharmaceuticals  schering  schering+pharmaceuticals  bayer+schering  pharm 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/20029
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Bayer-Schering Pharmaceuticals: A $20B Merger?:

  • Currently 9.33/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.33 out of 3 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!